Gastrointestinal cytoprotection: From basic science to clinical perspectives

Inflammopharmacology

Volumn 15, Issue 2, 2007, Pages 49-60

  Mozsik G ^a   Domotor A ^a   Rumi, G ^a   Szekeres, G ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Drugs; Gastric mucosal damage; Gastrointestinal cytoprotection; Human gastric ulcer; Human GI disorders; Retinoids

Indexed keywords

ATROPINE; BETA CAROTENE; CAPSAICIN; CAPSANTHIN; CARBENOXOLONE; CAROTENE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CRYPTOXANTHIN; PROSTACYCLIN; PROSTAGLANDIN E2; RETINOID; RETINOL; XANTHOPHYLL; ZEAXANTHIN;

ANTIOXIDANT ACTIVITY; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CLINICAL TRIAL; DNA DAMAGE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; MITOCHONDRION; MUCOSA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION;

ANIMALS; ANTIOXIDANTS; CYTOPROTECTION; DNA DAMAGE; GASTRIC ACID; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HUMANS; MITOCHONDRIA; MODELS, ANIMAL; NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 34247529397     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-1565-x     Document Type: Review

References (47)

1. Baur, H., Kasperek, S., Pfaff, E. 1975). Criteria of viability of isolated liver cells. Z. Physiol. hem. 356, 827-838.
2. Bergmeyer, H. U., Bern, T. E. (1974). Colorimetric assay with L(+) lactate, NAD, phenazone, methosulphate and INT, in: Methods in Enzymatic Analysi,. Bergmeyer, H. U. (Ed), pp. 579-582. Akademic Press, New York, USA.
3. Bódis, B., Karádi, O., Abdel-Salam, O. M. E., Faludi, R., Nagy, L., Mózsik, G. (1997a). Organoprotection and cytoprotection of histamine differs in rats. Infl ammopharmacology 5, 29-41.
4. Bódis, B., Karádi, O., Abdel-Salam, O. M. E., Vörös, S., Nagy, L., Mózsik, G. (1996). Direct cellular effect of Helicobacter pylori alone and with cotreatments of ethanol and indomethacin in mixed isolated rat gastric mucosa cells. Dig. Dis. Sci. 41, 430.
5. Bódis, B., Karádi, O., Szabó, I., Németh, P., Belágyi, J., Mózsik, G. (2000). Evidence for the involvement of oxygen free radicals in the ethanol-induced late cellular injury in mouse myeloma cells. J. Physiol. Paris. 94, 67-70.
6. Bódis, B., Karádi, O., Nagy, L., Dohoczky, C., Kolega, M., Mózsik, G. (1997b). Direct cellular effects of some mediators, hormones and growth factor-like agents on denervated (isolated) rat gastric mucosal cells. J. Physiol. Paris. 91, 183-187.
7. Bódis, B., Karádi, O., Németh, P., Dohoczky, C., Kolega, M., Mózsik, G. (1997c). Evidence for direct cellular protective effect of PL-10 substances (synthesized parts of body protection compound, BPC) and their specificity to gastric mucosal cells. Life Sci. 61, 243-248.
8. Bódis, B., Németh, P., Mózsik, G. (1998). Organoprotection and Cytoprotection in the Stomach. Akadémia Kiadó, Budapest, Hungary. Chaudhury, T. K., Jacobson, E. D. (1978). Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74, 58-63.
9. Dey, C. S., Majumder, G. C. (1989). A simple quantitative method of estimation of cell intactsness based on ethidium bromide fluorescens. Biochem. Int. 17, 367-374.
10. 2 and cimetidine on the beta-carotene induced cytoprotection in ethanol-treated rats. Acta Physiol. Hung. 73, 221-224.
11. Jávor, T., Bata, M., Lovász, L., Moron, F., Nagy, L., Patty, I. et al. (1983). Gastric cytoprotective effects of vitamin A and other carotenoidsl. Int. J. Tissue React. 5, 289-296.
12. Karádi, O., Mózsik, G. (2000). Surgical and Chemical Vagotomy on the Gastrintestinal Mucosal Defense. Akadémia Kiadó, Budapest, Hungary.
13. Moron, F., Jávor, T., Bata, M., Fiegler, M., Mózsik, G. (1982). The relationships between indomethacin-induced gastric ulcer, ulcer protection by cimetidine and prostacyclin and the cAMP system of the gastric fundic mucosa in the rat. Acta Physiol. Acad. Sci. Hung. 60, 149-153.
14. Moron, F., Mózsik, G., Nagy, L., Patty, I., Tárnok, F., Jávor, T. (1984). Evidence for the existence of gastric cytoprotective effect of atropine and cimetidine in humans. Acta Physiol. Hung. 65, 367-372.
15. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
16. Mózsik, G. (2005). Neural, hormonal and pharmacological regulation of retinoid-induced gastrointestinal mucosal protection. Recent Res. Devel. Life Sci. 3, 131-207.
17. Mózsik, G. (2006). Molecular pharmacology and biochemistry of gastroduodenal mucosal damage and protection. An overview of animal experiments and human observation. In: Discoveries in Gastroenterology (1960-2005), Mózsik, G. (Ed), pp. 139-224. Akadémiai Kiadó Budapest, Hungary.
18. Mózsik, G., Abdel-Salam, O. M. E., Szolcsányi, J. (1997). Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Damage and Protection. Akadémiai Kiadó, Budapest, Hungary.
19. Mózsik, G., Bertelli, A., Deák, G., Nagy, L., Patty, I., Simon, L. et al. (1985). Some aspects of the critical evaluation of peptic ulcer therapy in patients. Int. J. Clin. Pharmacol. Res. 5, 447-455.
20. Mózsik, G., Dömötör, A., Abdel-Salam, O. M. E. (2006). Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve in the gastric mucosal protection. Inflammopharmacology 14, 1-7.
21. Mózsik, G., Fiegler, M., Rumi, G. (2000). Membrane-bound, ATP-dependent energy systems and tissue hypoxia in human gastric mucosa. J. Gastroenterol. Hepatol. (Editorial) 15, 127-132.
22. Mózsik, G., Jávor, T. (1988). A biochemical and pharmacological approach to the genesis of ulcer disease. I. A model study of ethanol-induced injury to gastric mucosa in rats. Dig. Dis. .Sci. 33, 92-105.
23. Mózsik, G., Jávor, T. (1991). Therapy of ulcers with sulfhydryl and non-sulfhydryl antioxidants. In: Ulcer Disease, Investigation and Basis for Therapy Schwabb, E. and Szabó, S. (Eds). pp. 321-341. Marcel Dekker, New York, USA.
24. Mózsik, G., Jávor, T., Dobi, S. (1965). Clinical pharmalogical analysis of long term parasymmpotholytic treatment. In: Acta Testii Conventur Medicine Internal Hungarian. Gastroenterologia. Magyar, I. (Ed), pp, 709-715, Akadémiai kiadó Budapest, Hungary.
25. Mózsik, G., Jávor, T., Dobi, S., Petrassy, K., Szabó, A. (1967). Development of pharmacological denervation phenomenon' in patients treated with atropine. Eur. J. Pharmacol. 1, 391-395.
26. Mózsik, G., Király, Á., Garamszegi, M., Jávor, T., Nagy, L., Süt , G. et al. (1991). Failure of prostacyclin, β-carotene, atropine and cimetidine to produce gastric cyto- and general mucosal protection in surgically vagotomized rats. Life Sci. 49, 1383-1389.
27. Mózsik, G., Lovász, L., Kutor, G., Nagy, L., Tárnok, F. (1980). Experimental evidence for cytoprotective effect of atropine on the rat gastric mucosa. Acta Med. Acad. Sci. Hung. 37, 401-405.
28. Mózsik, G., Moron, F., Fiegler, M., Jávor, T., Nagy, L., Patty, I. et al. (1983). Interrelationships between membrane-bound ATP-dependent energy systems, gastric mucosal damage produced by NaOH, hypertonic NaCl, HCl, and alcohol, and prostacyclin-induced gastric cytoprotection in rats, Prostaglandins Leukot. Med. 12, 423-436.
29. Mózsik, G., Moron, F., Jávor, T. (1982). Cellular mechanisms of the development of gastric mucosal damage and of gastrocytoprotection induced by prostacyclin in rats. A pharmacological study, Prostaglandins Leukot. Med. 9, 71-84.
30. Mózsik, G., Moron, F., Nagy, L., Ruzsa, Cs., Tárnok, F., Jávor, T. (1986). Evidence of the gastric cytoprotective effects of vitamin A, atropine and cimetidine on the development of gastric mucosal damage produced by administration of indomethacin in healthy subjects, Int. J. Tiss. React. 8, 85-90.
31. Mózsik, G., Nagy, Z., Nagy, A., Rumi, G., Karádi, O., Czimmer, J. et al. (2001). Leiden mutation (as genetic) and environmental (retinoids) sequences in the acute and chronic inflammatory and premalignant colon disease in human gastrointestinal tract, J. Physiol. Paris. 95, 489-494.
32. Mózsik, G., Rumi G., Dömötör, A., Figler, M., Gasztonyi, B., Papp, E. et al. (2005a). Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary, World J. Gastroenterol. 11, 7646-7650.
33. Mózsik, G., Szolcsányi, J., Rácz, I. (2005b). Gastroprotection induced by capsaicin in healthy human subjects, World J. Gastroenterol. 11, 5180-5184.
34. Nagy, L., Mózsik, G., Feledi, E., Ruzsa, C., Vezekenyi, Z. Jávor, T. (1984). Gastric microbleeding measurements during one day treatment with indomethacin and indomethacin plus sodium salicylate (1:10) in patients, Acta Physiol. Hung. 64, 373-377.
35. Nagy, L., Szabó, S., Morales, R. E., Plebani, M., Jenkins, J. M. (1994). Identification of subcellular targets and sensitive tests of ethanol-induced damage in isolated rat gastric mucosal cells, Gastroenterology 107, 907-914.
36. Patty, I., Benedek, S, Deák, G., Jávor, T., Kenez, P., Nagy, L. et al. (1982). Controlled trial of vitamin A therapy in gastric ulcer, Lancet 2, 876.
37. Robert, A., Nezamis, J. E., Lancaster, C., Hanchar, A. (1979). Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury, Gastroenterology 77, 433-443.
38. Rumi, G. jr., Matus, Z., Tóth, G., Pár, A., Nagy, Z., Vincze, A. et al. (2001a). Changes of serum carotenoids in patients with esophageal, gastric, hepatocellular, pancreatic and colorectal cancer, J. Physiol. Paris. 95, 239-242.
39. Rumi, G. jr., Pár, A., Matus, Z., Rumi, G., Mózsik, G. (2001b). The Defensive Effects of Retinoids in the Gastrointestinal Tract, (Animal Experiments and Human Observations). Akadémia Kiadó, Budapest, Hungary.
40. Rumi, G., Szabó, I., Matus, Z., Vincze, Á., Tóth, G., Mózsik, G. (1999). Decrease of serum level of vitamin A and zeaxantin in patients with colorectal polyps, Eur. J. Gastroenterol. Hepatol. 11, 305-308.
41. Shay, H., Komarov, S. A., Fels, S. S., Meranze, D., Gurenstein, M., Siplet, H. (1945). A simple method for the uniform production of gastric ulceration in the rat, Gastroenterology 5, 46-61.
42. Sikiric, P., Petek, M., Rucman, R., Seiwerth, S., Grabarevic, Z., Rotkvic, I. et al. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC, J. Physiol. Paris. 87, 313-327.
43. Szabó, I., Bódis, B., Nagy, L., Mózsik, G. (1996). Methods for the examination of the direct injury and protective actions on the rat isolated gastric mucosal cells, Hung. Med. Weekly J. 137, 2687-2689.
44. Szabó, I., Bódis, B., Nagy, L., Mózsik, G. (1997a). Comparative studies of isolated gasrtic mucosa mixed cells and hepatoma and myeloma cell lines with ethanol indomethacin, and their combination, Inflammopharmacology 5, 83-91.
45. Szabó, I., Bódis, B., Németh, P., Mózsik, G. (1997b). Usage of scavengers on stable cultured (SP2/0-AG14 and HEP G2) cell lines as an approach to reveal the mechanisms of cytoprotection, In: Twenty Five Years of Peptic Ulcer Research in Hungary. From Basic Science to Clinical Practice 1975-1995, Mózsik, G., Nagy, L., Király, Á. (Eds), pp. 275-285. Akadémia Kiadó, Budapest, Hungary.
46. Szabó, I., Rumi, G., Bódis, B., Németh, P., Mózsik, G. (2000). Gastrin and pentagastrin enhance the tumour proliferation of human stable cultured gastric adenocarcinoma cells, J. Physiol. Paris. 94, 71-74.
47. Vincze, Á., Király, Á., Sütö, G., Karádi, O., Mózsik, G. (1997). Role of neurohumoral and local mucosal factors in β-carotene-induced gastroprotection in the rat, In: Twenty Five Years of Peptic Ulcer Research in Hungary. From Basic Science to Clinical Practice 1975-1995, Mózsik, G., Nagy, L., Király, Á. (Eds), pp. 275-285. Akadémia Kiadó, Budapest, Hungary.